Illumina Launches Two New Platforms at JP Morgan Conference; Claims $1,000 Genome | GenomeWeb

NEW YORK (GenomeWeb News) - Illumina President and CEO Jay Flatley today introduced two new sequencing platforms, new technological advances in the firm’s optics and flow cells, and reported preliminary fourth quarter figures for the firm.

He also said that the firm's technology can now produce a human genome for under $1,000, claiming to be the first to achieve this long sought-after goal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.